Friday, September 18, 2020

Lupin, Cipla to benefit from Perrigo’s recall of asthma drug albuterol sulphate MDI in the US

Lupin, Cipla to benefit from Perrigo’s recall of asthma drug albuterol sulphate MDI in the US Cipla has already launched the gProventil in April, while Lupin’s gProAir launch is expected this month. Dublin-based Perrigo recalled the device, saying some units may fail to dispense due to clogging

from Moneycontrol Business News https://www.moneycontrol.com/news/business/lupin-cipla-to-benefitperrigo’s-recallasthma-drug-albuterol-sulphate-mdithe-us_14287961.html

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...